← Back to catalogue

Lipase (lps)

FDA UDI

Class I (US FDA UDI)

by Randox Laboratories, Ltd.

Identity

Trade Name
LIPASE (LPS) FDA UDI
Generic Name
Lipase IVD, kit, spectrophotometry FDA UDI
Device Name
A Lipase test system is a device intended for the quantitative in vitro determination of Lipase in human serum and plasma FDA UDI
Model / Reference
LI3837 FDA UDI
Description
A Lipase test system is a device intended for the quantitative in vitro determination of Lipase in human serum and plasma FDA UDI

Identifiers

Catalog Number
LI3837 FDA UDI
Primary DI / UDI-DI
05055273204230 FDA UDI
FDA Product Code
CHI FDA UDI
GMDN Term
Lipase IVD, kit, spectrophotometry FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1465 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Lipase IVD, kit, spectrophotometry

Lipase (lps) by Randox Laboratories, Ltd. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Lipase IVD, kit, spectrophotometry.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI a11c3a8c-a71e-4e11-b26b-cfda7948d307 36 fields · synced May 29, 2026